When Bilirubin Stays at 10 Two Weeks After a Biliary Stent — Why Jaundice Can Persist After Drainage, and What to Watch While Chemotherapy Waits

When a tumor at the head of the pancreas presses on the bile duct, bile cannot drain into the intestine and bilirubin builds up in the blood. The eyes and skin turn yellow, urine darkens, stools lose their color, and itching often becomes constant. The usual first step is drainage — placing a stent through an endoscope (ERCP) to reopen the blocked duct. But numbers rarely fall the next morning. Bilirubin that has already accumulated must be reprocessed and excreted, so the decline is typically gradual over several days to two weeks. A flat reading in the first few days is not unusual.

What raises questions is a level that has barely moved after two weeks. Several explanations are possible. The stent may not fully bridge the blocked segment, or may have shifted. It may have clogged early with biliary sludge or with tumor growing through or around it. The blockage may involve several branches inside the liver, so that only part of the liver is actually draining — when too little liver volume is decompressed, the number stays high. Or extensive liver involvement may have reduced the liver's own processing capacity, so the level holds even after the path is open. Cholangitis (bile duct infection) and drug-related liver injury can also overlap.

Teams usually sort through this in steps: separating direct from indirect bilirubin, tracking ALP, GGT and liver enzymes, and imaging with ultrasound or CT to see whether the ducts are still dilated and where the stent sits. If dilated ducts remain, options include exchanging or upsizing the stent, or adding percutaneous drainage through the skin into the liver (PTBD). If the ducts have decompressed well but bilirubin remains high, attention shifts from plumbing to liver function. It is fair to ask directly what is being waited for, and at what point another procedure would be considered.

The delay in starting chemotherapy follows from the same physiology. Many cytotoxic drugs are metabolized in the liver and cleared into bile, so giving them while bilirubin is high can leave the drug in the body longer and amplify toxicity. Thresholds differ by drug — some can be started at a reduced dose, others are safer to postpone until the level falls. "We will start once the number comes down" usually means timing the start safely, not abandoning treatment.

The waiting period is not empty. Daily temperature checks matter most: a fever above 38°C with chills, right upper abdominal pain, or worsening jaundice in someone with a biliary stent suggests cholangitis and needs prompt medical review rather than watchful waiting at home. Brief notes on urine and stool color, itching, appetite and weight make short weekly visits far more useful.

Blood sugar deserves equal weight. The pancreas produces insulin, so pancreatic disease can worsen existing diabetes or unmask new diabetes. Add infection, physiological stress, certain medications and changing meal patterns, and post-meal readings above 400 mg/dL can appear. Repeated readings at that level risk dehydration and electrolyte problems, so it is safer to contact the treating team about adjusting medication than to wait for the next scheduled visit. Intense thirst, a large change in urine output, vomiting, rapid breathing, or unusual drowsiness are reasons to seek care immediately.

Ankle or leg discomfort should not be filed away as a minor complaint. It may reflect swelling from immobility or low albumin, pain from bone involvement, or venous thrombosis, which is more common in people with cancer. One-sided calf swelling with pain or warmth, or sudden breathlessness or chest pain, calls for urgent assessment. Symmetric swelling that pits when pressed can usually be discussed at the next appointment.

Some preparation can happen now: confirming biopsy and genomic testing status, asking which treatments are candidates for the next step, starting palliative care alongside oncology for pain, itching and appetite, discussing pancreatic enzyme replacement if stools are greasy or digestion is poor, and protecting weight with small frequent meals. Because overall functional status often determines whether treatment can begin at all, this stretch of time is closer to preparation than to standing still.

This article provides general health information and does not replace medical diagnosis or care. Interpretation of laboratory values and decisions about when to begin treatment differ from person to person — please discuss your situation with your own medical team.